Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
How to treat tumefactive demyelinating disease?
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
Control of TH17 cells occurs in the small intestine.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Antidepressant activity of fingolimod in mice.
Multiple sclerosis and pregnancy: maternal considerations.
Cannabis and Cannabinoids (PDQ®)
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Aspirin and multiple sclerosis.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »